Simba Gill
Officer, Director at Evelo Biosciences, Inc. (EVLO)
Simba Gill has filed 20 insider reports with the SEC since January 2021, as director at Foghorn Therapeutics Inc. (FHTX), director at Serina Therapeutics, Inc. (SER) and officer and director at Evelo Biosciences, Inc. (EVLO). Simba Gill made no open-market purchases or sales in the last 12 months. The latest filing, on June 25, 2026, reports grant or award at Foghorn Therapeutics Inc. (FHTX).
- Filings
- 20
- Companies
- 3
- Bought on market
- None
- Sold on market
- $11.6K
Companies where Simba Gill is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 34,061 | $1.72 | Jun 25, 2026 | ||||
| Directorsince April 2024 | $1.12 | Feb 17, 2026 | |||||
| Officer, Director | 17,758 | $11.6K | Nov 9, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 24, 2026FHTXSEC Form 4 filed by Director Gill SimbaForm 4Grant or award
- Feb 3, 2026SERSEC Form 4 filed by Director Gill SimbaForm 4Grant or award
- Jun 17, 2025FHTXSEC Form 4 filed by Director Gill SimbaForm 4Grant or award
- Jun 26, 2024FHTXSEC Form 4 filed by Director Gill SimbaForm 4Grant or award
- Apr 15, 2024SERSEC Form 4 filed by Gill SimbaForm 4Grant or award
- Apr 12, 2024SERSimba Gill became an insiderForm 3New insider
- Nov 8, 2023-$56.76EVLOGill Simba sold $57 worth of shares (172 units at $0.33) and converted options into 1,172 shares, increasing direct ownership by 6% to 17,758 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 28, 2023-$7,864EVLOGill Simba sold $7,864 worth of shares (1,996 units at $3.94) and converted options into 15,000 shares, increasing direct ownership by 346% to 16,758 unitsForm 4Grant or awardExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 8, 2023-$3,252EVLOSEC Form 4: Gill Simba converted options into 1,171 shares and sold $3,252 worth of shares (342 units at $9.51), increasing direct ownership by 28% to 3,754 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 21, 2023FHTXSEC Form 4 filed by Gill SimbaForm 4Grant or award
- Jun 8, 2023EVLOSEC Form 4 filed by Gill SimbaForm 4Grant or award
- May 8, 2023-$444EVLOSEC Form 4 filed by Gill SimbaForm 4Open-market sale10b5-1 plan
- May 7, 2023EVLOSEC Form 4 filed by Gill Simba (Amendment)Form 4Exercise or conversion of a derivative
- May 7, 2023EVLOSEC Form 4 filed by Gill SimbaForm 4Exercise or conversion of a derivative
- Feb 7, 2023EVLOSEC Form 4 filed by Gill SimbaForm 4Grant or award
- Sep 13, 2022FHTXSEC Form 4: Gill Simba exercised 82,000 shares at a strike of $0.73 and gifted 47,939 sharesForm 4GiftExercise or conversion of a derivative
- Jun 21, 2022FHTXSEC Form 4 filed by Gill SimbaForm 4Grant or award
- Jan 19, 2022EVLOSEC Form 4 filed by Gill SimbaForm 4Grant or award
- Jul 13, 2021FHTXSEC Form 4 filed by GILL SIMBAForm 4Grant or award
- Jan 27, 2021EVLOSEC Form 4 filed by Simba GillForm 4Grant or award
Compare Simba Gill with
- Simba Gill vs Farrell Simon1 shared
- Simba Gill vs Stephen K. Brannan1 shared
- Simba Gill vs Thomas J. Lynch Jr.1 shared
- Simba Gill vs Stuart Duty1 shared
- Simba Gill vs Scott Biller1 shared
- Simba Gill vs Neil Gallagher1 shared
Other insiders at the same companies
- Farrell SimonSER
- Stephen K. BrannanSER
- Thomas J. Lynch Jr.FHTX
- Stuart DutyFHTX
- Scott BillerFHTX
- Neil GallagherFHTX
- Michael MendelsohnFHTX
- Ian F SmithFHTX
- B Lynne ParshallFHTX
- Douglas G. ColeFHTX
- Jay VenkatesanSER
- Gregory BaileySER
- Karen J WilsonSER
- Richard Peter MarshallSER
- Steven A LedgerSER
- Srini TenjarlaSER
Questions about Simba Gill
- What is Simba Gill's role at Evelo Biosciences, Inc.?
- Simba Gill reports to the SEC as officer and director at Evelo Biosciences, Inc. (EVLO), according to the latest filing on November 9, 2023. Simba Gill has also filed as director at Foghorn Therapeutics Inc. (FHTX) and director at Serina Therapeutics, Inc. (SER).
- How many shares does Simba Gill own?
- After the latest filing that states it, Simba Gill directly owned 34,061 shares of Foghorn Therapeutics Inc. (FHTX) and 17,758 shares of Evelo Biosciences, Inc. (EVLO). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Simba Gill bought or sold stock recently?
- The most recent open-market sale was on November 8, 2023: sold 172 shares of Evelo Biosciences, Inc. (EVLO) for $56.76 at an average of $0.33.
- How do I get alerts when Simba Gill files?
- Follow Simba Gill on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Simba Gill (SEC CIK 0001180763). Totals count each trade once, skipping amendments whose original is on file, from Jan 29, 2021 on. View on SEC EDGAR · Get this as JSON